article thumbnail

Playing the Waiting Game While Living with a Rare Disease

Society for Participatory Medicine

In 2004, at age 17, I was diagnosed with an adult-onset muscle disease called limb-girdle muscular dystrophy type 2B (LGMD2B). And again, the more identified patients there are, especially for rare diseases, the better. Familiarize yourself with the drug development landscape. Take time to understand the research landscape.

article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

Understanding and Development (1990s-2000s): 1990s: Research delves into the GLP-1 receptor and its role in regulating metabolism. 2004: First GLP-1 receptor agonist (GLP-1 RA), exenatide, approved for type 2 diabetes treatment. 1996: Studies suggest GLP-1's potential in managing type 2 diabetes and obesity.